Global Opioids Drug Supply, Demand and Key Producers, 2026-2032
The global Opioids Drug market size is expected to reach $ 8680 million by 2032, rising at a market growth of -1.8% CAGR during the forecast period (2026-2032).
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report studies the global Opioids Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioids Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioids Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioids Drug total production and demand, 2021-2032, (M Units)
Global Opioids Drug total production value, 2021-2032, (USD Million)
Global Opioids Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Opioids Drug consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Opioids Drug domestic production, consumption, key domestic manufacturers and share
Global Opioids Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Opioids Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Opioids Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioids Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioids Drug Market, By Region:
1. How big is the global Opioids Drug market?
2. What is the demand of the global Opioids Drug market?
3. What is the year over year growth of the global Opioids Drug market?
4. What is the production and production value of the global Opioids Drug market?
5. Who are the key producers in the global Opioids Drug market?
6. What are the growth factors driving the market demand?
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
This report studies the global Opioids Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioids Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioids Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioids Drug total production and demand, 2021-2032, (M Units)
Global Opioids Drug total production value, 2021-2032, (USD Million)
Global Opioids Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Opioids Drug consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Opioids Drug domestic production, consumption, key domestic manufacturers and share
Global Opioids Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Opioids Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Opioids Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Opioids Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioids Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioids Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
1. How big is the global Opioids Drug market?
2. What is the demand of the global Opioids Drug market?
3. What is the year over year growth of the global Opioids Drug market?
4. What is the production and production value of the global Opioids Drug market?
5. Who are the key producers in the global Opioids Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 SCADA Introduction
1.2 World SCADA Market Size & Forecast (2021 & 2025 & 2032)
1.3 World SCADA Total Market by Region (by Headquarter Location)
1.3.1 World SCADA Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company SCADA Revenue (2021-2032)
1.3.3 China Based Company SCADA Revenue (2021-2032)
1.3.4 Europe Based Company SCADA Revenue (2021-2032)
1.3.5 Japan Based Company SCADA Revenue (2021-2032)
1.3.6 South Korea Based Company SCADA Revenue (2021-2032)
1.3.7 ASEAN Based Company SCADA Revenue (2021-2032)
1.3.8 India Based Company SCADA Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 SCADA Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World SCADA Consumption Value (2021-2032)
2.2 World SCADA Consumption Value by Region
2.2.1 World SCADA Consumption Value by Region (2021-2026)
2.2.2 World SCADA Consumption Value Forecast by Region (2027-2032)
2.3 United States SCADA Consumption Value (2021-2032)
2.4 China SCADA Consumption Value (2021-2032)
2.5 Europe SCADA Consumption Value (2021-2032)
2.6 Japan SCADA Consumption Value (2021-2032)
2.7 South Korea SCADA Consumption Value (2021-2032)
2.8 ASEAN SCADA Consumption Value (2021-2032)
2.9 India SCADA Consumption Value (2021-2032)
3 WORLD SCADA COMPANIES COMPETITIVE ANALYSIS
3.1 World SCADA Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global SCADA Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for SCADA in 2025
3.2.3 Global Concentration Ratios (CR8) for SCADA in 2025
3.3 SCADA Company Evaluation Quadrant
3.4 SCADA Market: Overall Company Footprint Analysis
3.4.1 SCADA Market: Region Footprint
3.4.2 SCADA Market: Company Product Type Footprint
3.4.3 SCADA Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: SCADA Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: SCADA Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: SCADA Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: SCADA Consumption Value Comparison
4.2.1 United States VS China: SCADA Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: SCADA Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based SCADA Companies and Market Share, 2021-2026
4.3.1 United States Based SCADA Companies, Headquarters (States, Country)
4.3.2 United States Based Companies SCADA Revenue, (2021-2026)
4.4 China Based Companies SCADA Revenue and Market Share, 2021-2026
4.4.1 China Based SCADA Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies SCADA Revenue, (2021-2026)
4.5 Rest of World Based SCADA Companies and Market Share, 2021-2026
4.5.1 Rest of World Based SCADA Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies SCADA Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World SCADA Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Hardware
5.2.2 Software
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World SCADA Market Size by Type (2021-2026)
5.3.2 World SCADA Market Size by Type (2027-2032)
5.3.3 World SCADA Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World SCADA Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Power & Energy
6.2.2 Oil & Gas Industry
6.2.3 Water & Waste Control
6.2.4 Telecommunications
6.2.5 Transportation
6.2.6 Manufacturing Industry
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World SCADA Market Size by Application (2021-2026)
6.3.2 World SCADA Market Size by Application (2027-2032)
6.3.3 World SCADA Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Schneider Electric SE (France)
7.1.1 Schneider Electric SE (France) Details
7.1.2 Schneider Electric SE (France) Major Business
7.1.3 Schneider Electric SE (France) SCADA Product and Services
7.1.4 Schneider Electric SE (France) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Schneider Electric SE (France) Recent Developments/Updates
7.1.6 Schneider Electric SE (France) Competitive Strengths & Weaknesses
7.2 ABB (Switzerland)
7.2.1 ABB (Switzerland) Details
7.2.2 ABB (Switzerland) Major Business
7.2.3 ABB (Switzerland) SCADA Product and Services
7.2.4 ABB (Switzerland) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 ABB (Switzerland) Recent Developments/Updates
7.2.6 ABB (Switzerland) Competitive Strengths & Weaknesses
7.3 Siemens AG (Germany)
7.3.1 Siemens AG (Germany) Details
7.3.2 Siemens AG (Germany) Major Business
7.3.3 Siemens AG (Germany) SCADA Product and Services
7.3.4 Siemens AG (Germany) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Siemens AG (Germany) Recent Developments/Updates
7.3.6 Siemens AG (Germany) Competitive Strengths & Weaknesses
7.4 Emerson (US)
7.4.1 Emerson (US) Details
7.4.2 Emerson (US) Major Business
7.4.3 Emerson (US) SCADA Product and Services
7.4.4 Emerson (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Emerson (US) Recent Developments/Updates
7.4.6 Emerson (US) Competitive Strengths & Weaknesses
7.5 Rockwell Automation Inc. (US)
7.5.1 Rockwell Automation Inc. (US) Details
7.5.2 Rockwell Automation Inc. (US) Major Business
7.5.3 Rockwell Automation Inc. (US) SCADA Product and Services
7.5.4 Rockwell Automation Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Rockwell Automation Inc. (US) Recent Developments/Updates
7.5.6 Rockwell Automation Inc. (US) Competitive Strengths & Weaknesses
7.6 Honeywell International Inc. (US)
7.6.1 Honeywell International Inc. (US) Details
7.6.2 Honeywell International Inc. (US) Major Business
7.6.3 Honeywell International Inc. (US) SCADA Product and Services
7.6.4 Honeywell International Inc. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Honeywell International Inc. (US) Recent Developments/Updates
7.6.6 Honeywell International Inc. (US) Competitive Strengths & Weaknesses
7.7 Mitsubishi Electric (Japan)
7.7.1 Mitsubishi Electric (Japan) Details
7.7.2 Mitsubishi Electric (Japan) Major Business
7.7.3 Mitsubishi Electric (Japan) SCADA Product and Services
7.7.4 Mitsubishi Electric (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Mitsubishi Electric (Japan) Recent Developments/Updates
7.7.6 Mitsubishi Electric (Japan) Competitive Strengths & Weaknesses
7.8 Omron Corporation (Japan)
7.8.1 Omron Corporation (Japan) Details
7.8.2 Omron Corporation (Japan) Major Business
7.8.3 Omron Corporation (Japan) SCADA Product and Services
7.8.4 Omron Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Omron Corporation (Japan) Recent Developments/Updates
7.8.6 Omron Corporation (Japan) Competitive Strengths & Weaknesses
7.9 General Electric Co. (US)
7.9.1 General Electric Co. (US) Details
7.9.2 General Electric Co. (US) Major Business
7.9.3 General Electric Co. (US) SCADA Product and Services
7.9.4 General Electric Co. (US) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 General Electric Co. (US) Recent Developments/Updates
7.9.6 General Electric Co. (US) Competitive Strengths & Weaknesses
7.10 Yokogawa Electric Corporation (Japan)
7.10.1 Yokogawa Electric Corporation (Japan) Details
7.10.2 Yokogawa Electric Corporation (Japan) Major Business
7.10.3 Yokogawa Electric Corporation (Japan) SCADA Product and Services
7.10.4 Yokogawa Electric Corporation (Japan) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Yokogawa Electric Corporation (Japan) Recent Developments/Updates
7.10.6 Yokogawa Electric Corporation (Japan) Competitive Strengths & Weaknesses
7.11 Larsen & Toubro (India)
7.11.1 Larsen & Toubro (India) Details
7.11.2 Larsen & Toubro (India) Major Business
7.11.3 Larsen & Toubro (India) SCADA Product and Services
7.11.4 Larsen & Toubro (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Larsen & Toubro (India) Recent Developments/Updates
7.11.6 Larsen & Toubro (India) Competitive Strengths & Weaknesses
7.12 M.B. Control & Systems Pvt. Ltd (India)
7.12.1 M.B. Control & Systems Pvt. Ltd (India) Details
7.12.2 M.B. Control & Systems Pvt. Ltd (India) Major Business
7.12.3 M.B. Control & Systems Pvt. Ltd (India) SCADA Product and Services
7.12.4 M.B. Control & Systems Pvt. Ltd (India) SCADA Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 M.B. Control & Systems Pvt. Ltd (India) Recent Developments/Updates
7.12.6 M.B. Control & Systems Pvt. Ltd (India) Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 SCADA Industry Chain
8.2 SCADA Upstream Analysis
8.3 SCADA Midstream Analysis
8.4 SCADA Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Opioids Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioids Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioids Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioids Drug Production Value Market Share by Region (2021-2026)
Table 5. World Opioids Drug Production Value Market Share by Region (2027-2032)
Table 6. World Opioids Drug Production by Region (2021-2026) & (M Units)
Table 7. World Opioids Drug Production by Region (2027-2032) & (M Units)
Table 8. World Opioids Drug Production Market Share by Region (2021-2026)
Table 9. World Opioids Drug Production Market Share by Region (2027-2032)
Table 10. World Opioids Drug Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Opioids Drug Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Opioids Drug Major Market Trends
Table 13. World Opioids Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Opioids Drug Consumption by Region (2021-2026) & (M Units)
Table 15. World Opioids Drug Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Opioids Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioids Drug Producers in 2025
Table 18. World Opioids Drug Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Opioids Drug Producers in 2025
Table 20. World Opioids Drug Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Opioids Drug Company Evaluation Quadrant
Table 22. World Opioids Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 24. Opioids Drug Market: Company Product Type Footprint
Table 25. Opioids Drug Market: Company Product Application Footprint
Table 26. Opioids Drug Competitive Factors
Table 27. Opioids Drug New Entrant and Capacity Expansion Plans
Table 28. Opioids Drug Mergers & Acquisitions Activity
Table 29. United States VS China Opioids Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioids Drug Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Opioids Drug Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioids Drug Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 37. China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 47. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioids Drug Production by Type (2021-2026) & (M Units)
Table 49. World Opioids Drug Production by Type (2027-2032) & (M Units)
Table 50. World Opioids Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioids Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioids Drug Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Opioids Drug Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioids Drug Production by Application (2021-2026) & (M Units)
Table 56. World Opioids Drug Production by Application (2027-2032) & (M Units)
Table 57. World Opioids Drug Production Value by Application (2021-2026) & (USD Million)
Table 58. World Opioids Drug Production Value by Application (2027-2032) & (USD Million)
Table 59. World Opioids Drug Average Price by Application (2021-2026) & (USD/Unit)
Table 60. World Opioids Drug Average Price by Application (2027-2032) & (USD/Unit)
Table 61. Teva Basic Information, Manufacturing Base and Competitors
Table 62. Teva Major Business
Table 63. Teva Opioids Drug Product and Services
Table 64. Teva Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Teva Recent Developments/Updates
Table 66. Teva Competitive Strengths & Weaknesses
Table 67. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Purdue Pharma Major Business
Table 69. Purdue Pharma Opioids Drug Product and Services
Table 70. Purdue Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Purdue Pharma Recent Developments/Updates
Table 72. Purdue Pharma Competitive Strengths & Weaknesses
Table 73. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 74. Mallinckrodt Major Business
Table 75. Mallinckrodt Opioids Drug Product and Services
Table 76. Mallinckrodt Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Mallinckrodt Recent Developments/Updates
Table 78. Mallinckrodt Competitive Strengths & Weaknesses
Table 79. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Amneal Pharma Major Business
Table 81. Amneal Pharma Opioids Drug Product and Services
Table 82. Amneal Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Amneal Pharma Recent Developments/Updates
Table 84. Amneal Pharma Competitive Strengths & Weaknesses
Table 85. Collegium Basic Information, Manufacturing Base and Competitors
Table 86. Collegium Major Business
Table 87. Collegium Opioids Drug Product and Services
Table 88. Collegium Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Collegium Recent Developments/Updates
Table 90. Collegium Competitive Strengths & Weaknesses
Table 91. J&J Basic Information, Manufacturing Base and Competitors
Table 92. J&J Major Business
Table 93. J&J Opioids Drug Product and Services
Table 94. J&J Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. J&J Recent Developments/Updates
Table 96. J&J Competitive Strengths & Weaknesses
Table 97. Endo Basic Information, Manufacturing Base and Competitors
Table 98. Endo Major Business
Table 99. Endo Opioids Drug Product and Services
Table 100. Endo Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Endo Recent Developments/Updates
Table 102. Endo Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Opioids Drug Product and Services
Table 106. Pfizer Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. INSYS Basic Information, Manufacturing Base and Competitors
Table 110. INSYS Major Business
Table 111. INSYS Opioids Drug Product and Services
Table 112. INSYS Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. INSYS Recent Developments/Updates
Table 114. INSYS Competitive Strengths & Weaknesses
Table 115. Mylan Basic Information, Manufacturing Base and Competitors
Table 116. Mylan Major Business
Table 117. Mylan Opioids Drug Product and Services
Table 118. Mylan Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Mylan Recent Developments/Updates
Table 120. Mylan Competitive Strengths & Weaknesses
Table 121. Hikma Basic Information, Manufacturing Base and Competitors
Table 122. Hikma Major Business
Table 123. Hikma Opioids Drug Product and Services
Table 124. Hikma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Hikma Recent Developments/Updates
Table 126. Hikma Competitive Strengths & Weaknesses
Table 127. Egalet Basic Information, Manufacturing Base and Competitors
Table 128. Egalet Major Business
Table 129. Egalet Opioids Drug Product and Services
Table 130. Egalet Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Egalet Recent Developments/Updates
Table 132. Egalet Competitive Strengths & Weaknesses
Table 133. Global Key Players of Opioids Drug Upstream (Raw Materials)
Table 134. Global Opioids Drug Typical Customers
Table 135. Opioids Drug Typical Distributors
Table 1. World Opioids Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioids Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioids Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioids Drug Production Value Market Share by Region (2021-2026)
Table 5. World Opioids Drug Production Value Market Share by Region (2027-2032)
Table 6. World Opioids Drug Production by Region (2021-2026) & (M Units)
Table 7. World Opioids Drug Production by Region (2027-2032) & (M Units)
Table 8. World Opioids Drug Production Market Share by Region (2021-2026)
Table 9. World Opioids Drug Production Market Share by Region (2027-2032)
Table 10. World Opioids Drug Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Opioids Drug Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Opioids Drug Major Market Trends
Table 13. World Opioids Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Opioids Drug Consumption by Region (2021-2026) & (M Units)
Table 15. World Opioids Drug Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Opioids Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioids Drug Producers in 2025
Table 18. World Opioids Drug Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Opioids Drug Producers in 2025
Table 20. World Opioids Drug Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Opioids Drug Company Evaluation Quadrant
Table 22. World Opioids Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioids Drug Production Site of Key Manufacturer
Table 24. Opioids Drug Market: Company Product Type Footprint
Table 25. Opioids Drug Market: Company Product Application Footprint
Table 26. Opioids Drug Competitive Factors
Table 27. Opioids Drug New Entrant and Capacity Expansion Plans
Table 28. Opioids Drug Mergers & Acquisitions Activity
Table 29. United States VS China Opioids Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioids Drug Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Opioids Drug Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Opioids Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioids Drug Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 37. China Based Opioids Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 42. Rest of World Based Opioids Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioids Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioids Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioids Drug Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Opioids Drug Production Market Share (2021-2026)
Table 47. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioids Drug Production by Type (2021-2026) & (M Units)
Table 49. World Opioids Drug Production by Type (2027-2032) & (M Units)
Table 50. World Opioids Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioids Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioids Drug Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Opioids Drug Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioids Drug Production by Application (2021-2026) & (M Units)
Table 56. World Opioids Drug Production by Application (2027-2032) & (M Units)
Table 57. World Opioids Drug Production Value by Application (2021-2026) & (USD Million)
Table 58. World Opioids Drug Production Value by Application (2027-2032) & (USD Million)
Table 59. World Opioids Drug Average Price by Application (2021-2026) & (USD/Unit)
Table 60. World Opioids Drug Average Price by Application (2027-2032) & (USD/Unit)
Table 61. Teva Basic Information, Manufacturing Base and Competitors
Table 62. Teva Major Business
Table 63. Teva Opioids Drug Product and Services
Table 64. Teva Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Teva Recent Developments/Updates
Table 66. Teva Competitive Strengths & Weaknesses
Table 67. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Purdue Pharma Major Business
Table 69. Purdue Pharma Opioids Drug Product and Services
Table 70. Purdue Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Purdue Pharma Recent Developments/Updates
Table 72. Purdue Pharma Competitive Strengths & Weaknesses
Table 73. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 74. Mallinckrodt Major Business
Table 75. Mallinckrodt Opioids Drug Product and Services
Table 76. Mallinckrodt Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Mallinckrodt Recent Developments/Updates
Table 78. Mallinckrodt Competitive Strengths & Weaknesses
Table 79. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Amneal Pharma Major Business
Table 81. Amneal Pharma Opioids Drug Product and Services
Table 82. Amneal Pharma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Amneal Pharma Recent Developments/Updates
Table 84. Amneal Pharma Competitive Strengths & Weaknesses
Table 85. Collegium Basic Information, Manufacturing Base and Competitors
Table 86. Collegium Major Business
Table 87. Collegium Opioids Drug Product and Services
Table 88. Collegium Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Collegium Recent Developments/Updates
Table 90. Collegium Competitive Strengths & Weaknesses
Table 91. J&J Basic Information, Manufacturing Base and Competitors
Table 92. J&J Major Business
Table 93. J&J Opioids Drug Product and Services
Table 94. J&J Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. J&J Recent Developments/Updates
Table 96. J&J Competitive Strengths & Weaknesses
Table 97. Endo Basic Information, Manufacturing Base and Competitors
Table 98. Endo Major Business
Table 99. Endo Opioids Drug Product and Services
Table 100. Endo Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Endo Recent Developments/Updates
Table 102. Endo Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Opioids Drug Product and Services
Table 106. Pfizer Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. INSYS Basic Information, Manufacturing Base and Competitors
Table 110. INSYS Major Business
Table 111. INSYS Opioids Drug Product and Services
Table 112. INSYS Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. INSYS Recent Developments/Updates
Table 114. INSYS Competitive Strengths & Weaknesses
Table 115. Mylan Basic Information, Manufacturing Base and Competitors
Table 116. Mylan Major Business
Table 117. Mylan Opioids Drug Product and Services
Table 118. Mylan Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Mylan Recent Developments/Updates
Table 120. Mylan Competitive Strengths & Weaknesses
Table 121. Hikma Basic Information, Manufacturing Base and Competitors
Table 122. Hikma Major Business
Table 123. Hikma Opioids Drug Product and Services
Table 124. Hikma Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Hikma Recent Developments/Updates
Table 126. Hikma Competitive Strengths & Weaknesses
Table 127. Egalet Basic Information, Manufacturing Base and Competitors
Table 128. Egalet Major Business
Table 129. Egalet Opioids Drug Product and Services
Table 130. Egalet Opioids Drug Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Egalet Recent Developments/Updates
Table 132. Egalet Competitive Strengths & Weaknesses
Table 133. Global Key Players of Opioids Drug Upstream (Raw Materials)
Table 134. Global Opioids Drug Typical Customers
Table 135. Opioids Drug Typical Distributors
LIST OF FIGURES
Figure 1. Opioids Drug Picture
Figure 2. World Opioids Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioids Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioids Drug Production (2021-2032) & (M Units)
Figure 5. World Opioids Drug Average Price (2021-2032) & (USD/Unit)
Figure 6. World Opioids Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Opioids Drug Production Market Share by Region (2021-2032)
Figure 8. North America Opioids Drug Production (2021-2032) & (M Units)
Figure 9. Europe Opioids Drug Production (2021-2032) & (M Units)
Figure 10. Israel Opioids Drug Production (2021-2032) & (M Units)
Figure 11. Opioids Drug Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Opioids Drug Consumption (2021-2032) & (M Units)
Figure 14. World Opioids Drug Consumption Market Share by Region (2021-2032)
Figure 15. United States Opioids Drug Consumption (2021-2032) & (M Units)
Figure 16. China Opioids Drug Consumption (2021-2032) & (M Units)
Figure 17. Europe Opioids Drug Consumption (2021-2032) & (M Units)
Figure 18. Japan Opioids Drug Consumption (2021-2032) & (M Units)
Figure 19. South Korea Opioids Drug Consumption (2021-2032) & (M Units)
Figure 20. ASEAN Opioids Drug Consumption (2021-2032) & (M Units)
Figure 21. India Opioids Drug Consumption (2021-2032) & (M Units)
Figure 22. Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Opioids Drug Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Opioids Drug Markets in 2025
Figure 25. United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Opioids Drug Production Market Share 2025
Figure 29. China Based Manufacturers Opioids Drug Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Opioids Drug Production Market Share 2025
Figure 31. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Opioids Drug Production Value Market Share by Type in 2025
Figure 33. Oxycodone
Figure 34. Hydromorphone
Figure 35. Codeine
Figure 36. Fentanyl
Figure 37. World Opioids Drug Production Market Share by Type (2021-2032)
Figure 38. World Opioids Drug Production Value Market Share by Type (2021-2032)
Figure 39. World Opioids Drug Average Price by Type (2021-2032) & (USD/Unit)
Figure 40. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Opioids Drug Production Value Market Share by Application in 2025
Figure 42. Pain Relief
Figure 43. Anesthesia
Figure 44. Others
Figure 45. World Opioids Drug Production Market Share by Application (2021-2032)
Figure 46. World Opioids Drug Production Value Market Share by Application (2021-2032)
Figure 47. World Opioids Drug Average Price by Application (2021-2032) & (USD/Unit)
Figure 48. Opioids Drug Industry Chain
Figure 49. Opioids Drug Procurement Model
Figure 50. Opioids Drug Sales Model
Figure 51. Opioids Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Opioids Drug Picture
Figure 2. World Opioids Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioids Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioids Drug Production (2021-2032) & (M Units)
Figure 5. World Opioids Drug Average Price (2021-2032) & (USD/Unit)
Figure 6. World Opioids Drug Production Value Market Share by Region (2021-2032)
Figure 7. World Opioids Drug Production Market Share by Region (2021-2032)
Figure 8. North America Opioids Drug Production (2021-2032) & (M Units)
Figure 9. Europe Opioids Drug Production (2021-2032) & (M Units)
Figure 10. Israel Opioids Drug Production (2021-2032) & (M Units)
Figure 11. Opioids Drug Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Opioids Drug Consumption (2021-2032) & (M Units)
Figure 14. World Opioids Drug Consumption Market Share by Region (2021-2032)
Figure 15. United States Opioids Drug Consumption (2021-2032) & (M Units)
Figure 16. China Opioids Drug Consumption (2021-2032) & (M Units)
Figure 17. Europe Opioids Drug Consumption (2021-2032) & (M Units)
Figure 18. Japan Opioids Drug Consumption (2021-2032) & (M Units)
Figure 19. South Korea Opioids Drug Consumption (2021-2032) & (M Units)
Figure 20. ASEAN Opioids Drug Consumption (2021-2032) & (M Units)
Figure 21. India Opioids Drug Consumption (2021-2032) & (M Units)
Figure 22. Producer Shipments of Opioids Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Opioids Drug Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Opioids Drug Markets in 2025
Figure 25. United States VS China: Opioids Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Opioids Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioids Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Opioids Drug Production Market Share 2025
Figure 29. China Based Manufacturers Opioids Drug Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Opioids Drug Production Market Share 2025
Figure 31. World Opioids Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Opioids Drug Production Value Market Share by Type in 2025
Figure 33. Oxycodone
Figure 34. Hydromorphone
Figure 35. Codeine
Figure 36. Fentanyl
Figure 37. World Opioids Drug Production Market Share by Type (2021-2032)
Figure 38. World Opioids Drug Production Value Market Share by Type (2021-2032)
Figure 39. World Opioids Drug Average Price by Type (2021-2032) & (USD/Unit)
Figure 40. World Opioids Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Opioids Drug Production Value Market Share by Application in 2025
Figure 42. Pain Relief
Figure 43. Anesthesia
Figure 44. Others
Figure 45. World Opioids Drug Production Market Share by Application (2021-2032)
Figure 46. World Opioids Drug Production Value Market Share by Application (2021-2032)
Figure 47. World Opioids Drug Average Price by Application (2021-2032) & (USD/Unit)
Figure 48. Opioids Drug Industry Chain
Figure 49. Opioids Drug Procurement Model
Figure 50. Opioids Drug Sales Model
Figure 51. Opioids Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
